USPTO serial 77088747
AMDREY
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- PENDLETON, CAROLYN A
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with AMDREY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maury M. Tepper, III
MAURY M. TEPPER, III WOMBLE CARLYLE SANDRIDGE & RICE, PLLCPO BOX 831RALEIGH, NC 27602-0831UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | (Based on Intent to Use) Diagnostic preparations for medical and veterinary use; Pharmaceutical preparations for the treatment of and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, diabetes and metabolic diseases, for use in dermatology, in oncology, in hematology, in transplantation, in ophthalmology, for use in the gastroenterological area and in the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for treating bacteria-based diseases, anti-infectives, anti-bacterials, antivirals, anti-biotics, anti-fungals, vaccines(Based on 44(e)) Pharmaceutical preparations for the treatment of and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, diabetes and metabolic diseases, for use in dermatology, in oncology, in hematology, in transplantation, in ophthalmology, for use in the gastroenterological area and in the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for treating bacteria-based diseases, anti-infectives, anti-bacterials, antivirals, anti-biotics, anti-fungals, vaccines | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 8, 2008 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 8, 2008 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 15, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 20, 2007 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 28, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 8, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| May 22, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 22, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 8, 2007 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 8, 2007 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 7, 2007 | ALIE | ASSIGNED TO LIE | — |
| May 4, 2007 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 4, 2007 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 2, 2007 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 2, 2007 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 2, 2007 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 19, 2007 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 19, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 12, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 26, 2007 | NWAP | NEW APPLICATION ENTERED | — |